孕期血栓栓塞性疾病的抗凝治疗。
Anticoagulant therapy of thromboembolic disease during pregnancy.
作者信息
Wehrmacher W H, Karlman R L, Scanlon P, Messmore H L
机构信息
Department of Physiology, Loyola University Chicago, Stritch School of Medicine, Maywood, IL 60153, USA.
出版信息
Compr Ther. 1998 Jun-Jul;24(6-7):289-94.
PMID:9669092
Abstract
There is growing interest in low molecular weight heparin for the management of thromboembolic disease in pregnancy. Greater understanding of the risk of thromboembolic disease versus the risk of various management practices is urgently needed to reduce maternal mortality and embryopathy in the fetus.
摘要
对于低分子量肝素在孕期血栓栓塞性疾病管理中的应用，人们的兴趣日益浓厚。迫切需要更深入地了解血栓栓塞性疾病的风险与各种管理措施的风险，以降低孕产妇死亡率和胎儿的胚胎病。
Zotero 插件